https://www.selleckchem.com/products/10074-g5.html
Background Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Pediatric-onset MS (POMS), defined as onset of MS before 18 years of age, is estimated to account for 2% to 5% of the MS population worldwide. Objectives To conduct a literature review focused on the healthcare resource utilization and cost as well as quality-of-life (QOL) outcomes among patients with POMS. Methods We conducted a systematic literature review of English-language studies published after September 2010 in MEDLINE
Like
Comment
Share
